Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C24H52NO6P
CAS Number:
Molecular Weight:
481.65
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
Product Name
C16 Lyso PAF, Avanti Research™ - A Croda Brand 878119P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 5 mg (878119P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 878119P
lipid type
bioactive lipids
phosphoglycerides
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCC
InChI
1S/C24H52NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-29-22-24(26)23-31-32(27,28)30-21-19-25(2,3)4/h24,26H,5-23H2,1-4H3/t24-/m1/s1
InChI key
VLBPIWYTPAXCFJ-XMMPIXPASA-N
Application
C16 Lyso PAF is suitable for the use in thin layer chromatography for the synthesis of acyl-platelet activating factor (PAF). It is also suitable for intraperitoneal injection into mice to compare the relative inhibitory actions of acyl-PAF, lyso-PC and lyso-PAF on alkyl PAF-induced death.
Packaging
5 mL Amber Glass Screw Cap Vial (878119P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Still not finding the right product?
Explore all of our products under C16 Lyso PAF
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
Chaithra VH, et al.
Journal of Lipid Research, 59(11), 2063-2074 (2018)
Kelsey B Law et al.
Autophagy, 13(5), 868-884 (2017-05-20)
Peroxisome biogenesis disorders (PBDs) are metabolic disorders caused by the loss of peroxisomes. The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal
Michael A Kennedy et al.
PLoS genetics, 10(1), e1004010-e1004010 (2014-01-28)
Unbiased lipidomic approaches have identified impairments in glycerophosphocholine second messenger metabolism in patients with Alzheimer's disease. Specifically, we have shown that amyloid-β42 signals the intraneuronal accumulation of PC(O-16:0/2:0) which is associated with neurotoxicity. Similar to neuronal cells, intracellular accumulation of
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 878119P-5MG | 04061835353903 |